Cargando…

Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic

Detalles Bibliográficos
Autores principales: Das, Ashis K., Chang, Eunice, Paydar, Caleb, Broder, Michael S., Orroth, Kate K., Cordey, Myriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442299/
https://www.ncbi.nlm.nih.gov/pubmed/37482565
http://dx.doi.org/10.1007/s13555-023-00984-2
_version_ 1785093562469187584
author Das, Ashis K.
Chang, Eunice
Paydar, Caleb
Broder, Michael S.
Orroth, Kate K.
Cordey, Myriam
author_facet Das, Ashis K.
Chang, Eunice
Paydar, Caleb
Broder, Michael S.
Orroth, Kate K.
Cordey, Myriam
author_sort Das, Ashis K.
collection PubMed
description
format Online
Article
Text
id pubmed-10442299
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-104422992023-08-23 Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic Das, Ashis K. Chang, Eunice Paydar, Caleb Broder, Michael S. Orroth, Kate K. Cordey, Myriam Dermatol Ther (Heidelb) Correction Springer Healthcare 2023-07-23 /pmc/articles/PMC10442299/ /pubmed/37482565 http://dx.doi.org/10.1007/s13555-023-00984-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Das, Ashis K.
Chang, Eunice
Paydar, Caleb
Broder, Michael S.
Orroth, Kate K.
Cordey, Myriam
Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
title Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
title_full Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
title_fullStr Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
title_full_unstemmed Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
title_short Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
title_sort correction: apremilast adherence and persistence in patients with psoriasis and psoriatic arthritis in the telehealth setting versus the in-person setting during the covid-19 pandemic
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442299/
https://www.ncbi.nlm.nih.gov/pubmed/37482565
http://dx.doi.org/10.1007/s13555-023-00984-2
work_keys_str_mv AT dasashisk correctionapremilastadherenceandpersistenceinpatientswithpsoriasisandpsoriaticarthritisinthetelehealthsettingversustheinpersonsettingduringthecovid19pandemic
AT changeunice correctionapremilastadherenceandpersistenceinpatientswithpsoriasisandpsoriaticarthritisinthetelehealthsettingversustheinpersonsettingduringthecovid19pandemic
AT paydarcaleb correctionapremilastadherenceandpersistenceinpatientswithpsoriasisandpsoriaticarthritisinthetelehealthsettingversustheinpersonsettingduringthecovid19pandemic
AT brodermichaels correctionapremilastadherenceandpersistenceinpatientswithpsoriasisandpsoriaticarthritisinthetelehealthsettingversustheinpersonsettingduringthecovid19pandemic
AT orrothkatek correctionapremilastadherenceandpersistenceinpatientswithpsoriasisandpsoriaticarthritisinthetelehealthsettingversustheinpersonsettingduringthecovid19pandemic
AT cordeymyriam correctionapremilastadherenceandpersistenceinpatientswithpsoriasisandpsoriaticarthritisinthetelehealthsettingversustheinpersonsettingduringthecovid19pandemic